Similarly, studies on CSF mononuclear cells obtained from patients with MS revealed that higher mRNA expression of TIM-1 associated with clinical remissions and low expression of IFN-γ [15], which could be due to the regulatory role of TIM-1 in inflammation. The gene discussed is IFNG; the disease is myeloid sarcoma.